BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹71 Cr | ₹88 Cr | ₹98 Cr | ₹105 Cr | ₹119 Cr |
What is the latest Total Debt ratio of BLISS GVS PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹71 Cr |
| Mar2024 | ₹88 Cr |
| Mar2023 | ₹98 Cr |
| Mar2022 | ₹105 Cr |
| Mar2021 | ₹119 Cr |
How is Total Debt of BLISS GVS PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹71 Cr | -19.17 | |
| Mar2024 | ₹88 Cr | -10.46 | |
| Mar2023 | ₹98 Cr | -6.56 | |
| Mar2022 | ₹105 Cr | -11.62 | |
| Mar2021 | ₹119 Cr | - | |
Compare Total Debt of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹4,648.9 Cr | 10.9% | 60.1% | 228.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,349.0 Cr | -3% | -1.9% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,543.0 Cr | -3.3% | -0.7% | -1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,884.0 Cr | -3.8% | 2.8% | 36.4% | Stock Analytics | |
| CIPLA | ₹111,077.0 Cr | -3% | 3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,388.0 Cr | -4.3% | -2% | 2.5% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 10.9% |
60.1% |
228.7% |
| SENSEX | -2.2% |
-3.3% |
-8.8% |
You may also like the below Video Courses